Atlas Trials

Targeted Limbic Self-modulation as a Potential Treatment for Patients Suffering From Fibromyalgia

Clinical trial NCT02146495 · COMPLETED

Trial details

NCT number
NCT02146495
Sponsor
Tel-Aviv Sourasky Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Fibromyalgia (FM)
Start date
2017-01-01
Primary completion
2022-08-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.